Advertisement

Topics

SanBio Co., Ltd. Company Profile

13:39 EDT 20th October 2018 | BioPortfolio

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research, development and clinical trials. The company has completed enrollment for and is conducting a Phase 2b clinical trial for its proprietary regenerative medical product SB623 for the treatment of chronic motor impairments resulting from stroke with its joint development partner, Sunovion Pharmaceuticals Inc., an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., in the United States and Canada. It is also conducting a Phase 2 clinical trial to evaluate the safety and efficacy of SB623 to treat impairments resulting from traumatic brain injury. Enrollment for that trial is close to complete. More information about SanBio, Inc., is available at http://sanbio.com.


News Articles [15 Associated News Articles listed on BioPortfolio]

SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based...

SanBio acquires MSC patent portfolio from Tulane U.

SanBio Co. Ltd. acquired Tulane University's patent portfolio surrounding cell therapies derived from mesenchymal stem cells (MSCs; multipotent cells capable of self-renewing and differentiating into ...

Notice of Personnel Changes to Corporate Officers at SanBio Co., Ltd. and at US Subsidiary SanBio, Inc.

SanBio Co., Ltd. and US subsidiary SanBio, Inc. conducted the following personnel transfers, effective October 1, 2018. 1. Transfer DetailsAkihiro Tsujimura will become a...

SanBio buys patent portfolio regarding cell medicines derived from MSCs

The patent portfolio includes technology discovered by Aline Betancourt, a researcher at Tulane University. Betancourt’s technology optimizes anti-inflammatory and pro-inflammatory functions of MSCs...

Research Paper Co-authored by Dr. Damien Bates, Chief Medical Officer and Head of Medical Research at SanBio Group, Published in Stroke

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that

SanBio: Acquisition of a Patent Portfolio Regarding Cell Medicines Derived from Mesenchymal ...

Read more...

SanBio: Update on Development Progress of Regenerative Cell Medicine SB623

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.) (TOKYO:4592) has updated part of its March 13, 2018 release “Update on Development Progress of Regenerative Cell M...

SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623

SanBio Co., Ltd. (representative: Keita Mori, headquarters: Chuo-ku, Tokyo; hereinafter SanBio) has agreed to enter into an equity and business alliance with CareNet, Inc. (repres...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

SanBio, Inc.

SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is be...

SanBio Co., Ltd.

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research...

SANBIO BV

Through regular contact with our customers in the Benelux and Germany, Sanbio has been able to offer a wide range of biotechnology and research products in the field of immunology, pathology, molecula...

SanBio Inc.

SanBio, Co. Ltd.

More Information about "SanBio Co., Ltd." on BioPortfolio

We have published hundreds of SanBio Co., Ltd. news stories on BioPortfolio along with dozens of SanBio Co., Ltd. Clinical Trials and PubMed Articles about SanBio Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SanBio Co., Ltd. Companies in our database. You can also find out about relevant SanBio Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record